The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression
Khalil Choucair(The Barbara Ann Karmanos Cancer Institute), Jacques Lapointe(Université Laval), Ladan Fazli, Kanishka Sircar(McGill University), Isabela Werneck da Cunha(AC Camargo Hospital), Fadi Brimo(McGill University Health Centre), Eleonora Scarlata(McGill University Health Centre), Joshua Ejdelman(McGill University Health Centre), Martin Gleave(University of British Columbia), Karl‐Philippe Guérard(McGill University Health Centre), Maisa Yoshimoto(University of Alberta), Jeremy A. Squire(Universidade de São Paulo), Armen Aprikian, Simone Chevalier
Cited by 39
Related Papers
The Molecular Taxonomy of Primary Prostate Cancer
|Cell|2015|3.3k
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Interstitial Cells of Cajal as Precursors of Gastrointestinal Stromal Tumors
|The American Journal of Surgical Pathology|1999|567
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
|Cancer Discovery|2018|520
Antisense therapy for cancer
|Nature reviews. Cancer|2005|399